Literature DB >> 11959007

Benzimidazole-4,7-diones as inhibitors of protozoal (Toxoplasma gondii) purine nucleoside phosphorylase.

Frédéric Alvarez1, Arnaud Ghérardi, Pascal Nebois, Marie Elizabeth Sarciron, Anne Françoise Pétavy, Nadia Walchshofer.   

Abstract

Benzimidazole-4,7-diones derivatives substituted at 1- and/or 2-position have been synthetized and tested as inhibitors of purine nucleoside phosphorylase (PNP), isolated from two strains of Toxoplasma gondii (RH and ME 49). They were identified as inhibitors of both enzymes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11959007     DOI: 10.1016/s0960-894x(02)00064-1

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

1.  Triazole-based compound as a candidate to develop novel medicines to treat toxoplasmosis.

Authors:  Katarzyna Dzitko; Agata Paneth; Tomasz Plech; Jakub Pawełczyk; Lidia Węglińska; Piotr Paneth
Journal:  Antimicrob Agents Chemother       Date:  2014-10-06       Impact factor: 5.191

2.  Synthesis of N-Fused Benzimidazole-4,7-diones via Sequential Copper-Catalyzed C-N Coupling/Cyclization and Oxidation.

Authors:  Pham Duy Quang Dao; Son Long Ho; Chan Sik Cho
Journal:  ACS Omega       Date:  2018-05-25

3.  Synthesis and anti-Toxoplasma activity of indole-triazole compounds on tachyzoites of RH strain.

Authors:  Mohammad Saleh Bahreini; Aida Iraji; Najmeh Edraki; Ali Arab Monfared; Qasem Asgari
Journal:  Ann Med Surg (Lond)       Date:  2022-01-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.